1990至2050年全球0-19岁儿童青少年1型糖尿病总发病率估算:基于全球模拟分析
本研究开发了1型糖尿病全球微观模拟模型,模拟200个国家和地区0-19岁儿童青少年的自然史与诊断过程,校准1990-2020年数据。估计2021年全球新发355900例(95%UI 334200-377300),其中56%(200400例,95%UI 180600-219500)被诊断。预计2050年新发病例增至476700例(95%UI 449500-504300),近半数儿童未诊断。
要点
- 2021年全球0-19岁1型糖尿病新发355900例,仅56%被诊断。
- 未诊断比例地区差异大:澳新、西欧北欧、北美超95%诊断,西非、南亚东南亚、美拉尼西亚不足35%。
- 预计2050年新发病例增至476700例,非洲新增病例数最高。
核心结论
- 全球儿童青少年1型糖尿病总发病率高于既往估计,近半数儿童未诊断。
- policymaker应规划充足诊断和医疗能力以改善及时检测和治疗,尤其全球发病率预计上升且非洲新增病例数最高。
研究设计与样本
- 开发1型糖尿病全球微观模拟模型,模拟200个国家和地区0-19岁儿童青少年自然史和诊断。
- 模型以月为间隔追踪开放人群,模拟发病、进展及影响诊断的卫生系统因素。
- 使用1990-2020年已发表的1型糖尿病发病率、自身抗体谱和糖尿病酮症酸中毒诊断比例数据校准,并用随机抽样测试集评估预测准确性。
主要发现
- 2021年全球0-19岁新发1型糖尿病355900例(95%UI 334200-377300),其中诊断200400例(95%UI 180600-219500),占56%。
- 澳大利亚和新西兰、西欧和北欧、北美诊断新发病例超过95%;西非、南亚和东南亚、美拉尼西亚诊断新发病例不足35%。
- 预计2050年儿童1型糖尿病新发病例总数增至476700例(95%UI 449500-504300)。
临床怎么用
- 原文未据此给出推荐。
- 作者指出政策制定者应规划充足诊断和医疗能力以改善及时检测和治疗,尤其全球发病率预计上升且非洲新增病例数最高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies of type 1 diabetes in childhood and adolescence have found large variations in reported incidence around the world. However, it is unclear whether these reported incidence levels are impacted by differences in country health systems and possible underdiagnosis and if so, to what degree. The aim of this study was to estimate both the total and diagnosed incidence of type 1 diabetes globally and to project childhood type 1 diabetes incidence indicators from 1990 to 2050 for each country. METHODS: We developed the type 1 diabetes global microsimulation model to simulate the natural history and diagnosis of type 1 diabetes for children and adolescents (aged 0-19 years) in 200 countries and territories, accounting for variability in underlying incidence and health system performance. The model follows an open population of children and adolescents in monthly intervals and simulates type 1 diabetes incidence and progression, as well as health system factors which influence diagnosis. We calibrated the model to published data on type 1 diabetes incidence, autoantibody profiles, and proportion of cases diagnosed with diabetic ketoacidosis from 1990 to 2020 and assessed the predictive accuracy using a randomly sampled test set of data withheld from calibration. FINDINGS: We estimate that in 2021 there were 355 900 (95% UI 334 200-377 300) total new cases of type 1 diabetes globally among children and adolescents, of which 56% (200 400 cases, 95% UI 180 600-219 500) were diagnosed. Estimated underdiagnosis varies substantially by region, with over 95% of new cases diagnosed in Australia and New Zealand, western and northern Europe, and North America, but less than 35% of new cases diagnosed in west Africa, south and southeastern Asia, and Melanesia. The total number of incident childhood cases of type 1 diabetes is projected to increase to 476 700 (95% UI 449 500-504 300) in 2050. INTERPRETATION: Our research indicates that the total global incidence of childhood and adolescent type 1 diabetes is larger than previously estimated, with nearly one-in-two children currently undiagnosed. Policymakers should plan for adequate diagnostic and medical capacity to improve timely type 1 diabetes detection and treatment, particularly as incidence is projected to increase worldwide, with highest numbers of new cases in Africa. FUNDING: Novo Nordisk.
引用
- Ward ZJ, Yeh JM, Reddy CL, et al. Estimating the total incidence of type 1 diabetes in children and adolescents aged 0-19 years from 1990 to 2050: a global simulation-based analysis. Lancet Diabetes Endocrinol. 2022. PMID: 36372070. doi:10.1016/S2213-8587(22)00276-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。